Hyliion is trading 9.1% up at $4.28 as broad risk appetite improves following the Federal Reserve’s September 16 rate hike.
- The S&P 500 is up 0.92% and Nasdaq Composite 1.26%, supporting a rebound in growth-oriented and speculative stocks.
- No new company-specific announcement dated September 17 was identified.
- Recent lawsuit notices and August earnings news appear stale; the move is best attributed to global market sentiment rather than a fresh corporate catalyst.